Literature DB >> 8642632

Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

J Gall1, A Kass-Eisler, L Leinwand, E Falck-Pedersen.   

Abstract

The efficient uptake of adenovirus into a target cell is a function of adenovirus capsid proteins and their interaction with the host cell. The capsid protein fiber mediates high-affinity attachment of adenovirus to the target cell. Although the cellular receptor(s) for adenovirus is unknown, evidence indicates that a single receptor does not function as the attachment site for each of the 49 different serotypes of adenovirus. Sequence variation of the fiber ligand, particularly in the C- terminal knob domain, is associated with serotype-specific binding specificity. Additionally, this domain of fiber functions as a major serotype determinant. Fiber involvement in cell targeting and its function as a target of the host immune response make the fiber gene an attractive target for manipulation, both from the perspective of adenovirus biology and from the perspective of using adenovirus vectors for gene transfer experiments. We have constructed a defective chimeric adenovirus type 5 (Ad5) reporter virus by replacing the Ad5 fiber gene with the fiber gene from Ad7A. Using the chloramphenicol acetyltransferase reporter gene, we have characterized this virus with respect to infectivity both in vitro and in vivo. We have also characterized the role of antifiber antibody in the host neutralizing immune response to adenovirus infection. Our studies demonstrate that exchange of fiber is a strategy that will be useful in characterizing receptor tropism for different serotypes of adenovirus. Additionally, the neutralizing immune response to Ad5 and Ad7 does not differentiate between two viruses that differ only in their fiber proteins. Therefore, following a primary adenovirus inoculation, antibodies generated against fiber do not constitute a significant fraction of the neutralizing antibody population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642632      PMCID: PMC190048     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Characterization of the early region 3 and fiber genes of Ad7.

Authors:  J S Hong; K G Mullis; J A Engler
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

2.  Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

Authors:  C Defer; M T Belin; M L Caillet-Boudin; P Boulanger
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

3.  Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment.

Authors:  T J Wickham; P Mathias; D A Cheresh; G R Nemerow
Journal:  Cell       Date:  1993-04-23       Impact factor: 41.582

4.  Adenovirus terminal protein mediates both nuclear matrix association and efficient transcription of adenovirus DNA.

Authors:  J Schaack; W Y Ho; P Freimuth; T Shenk
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

5.  Role of vesicles during adenovirus 2 internalization into HeLa cells.

Authors:  U Svensson
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

6.  Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera.

Authors:  C E Wohlfart; U K Svensson; E Everitt
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms.

Authors:  C Wohlfart
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

8.  Infectious entry pathway of adenovirus type 2.

Authors:  M J Varga; C Weibull; E Everitt
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

9.  Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells.

Authors:  M Bai; B Harfe; P Freimuth
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Adenovirus type 40 virions contain two distinct fibers.

Authors:  A H Kidd; J Chroboczek; S Cusack; R W Ruigrok
Journal:  Virology       Date:  1993-01       Impact factor: 3.616

View more
  77 in total

1.  Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

Authors:  N Miyazawa; P L Leopold; N R Hackett; B Ferris; S Worgall; E Falck-Pedersen; R G Crystal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Rapid assessment of adenovirus serum neutralizing antibody titer based on quantitative, morphometric evaluation of capsid binding and intracellular trafficking: population analysis of adenovirus capsid association with cells is predictive of adenovirus infectivity.

Authors:  T Vincent; B G Harvey; S M Hogan; C J Bailey; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein.

Authors:  N Miyazawa; R G Crystal; P L Leopold
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  CAR-dependent and CAR-independent pathways of adenovirus vector-mediated gene transfer and expression in human fibroblasts.

Authors:  C Hidaka; E Milano; P L Leopold; J M Bergelson; N R Hackett; R W Finberg; T J Wickham; I Kovesdi; P Roelvink; R G Crystal
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Dependence of adenovirus infectivity on length of the fiber shaft domain.

Authors:  D M Shayakhmetov; A Lieber
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Artificial extension of the adenovirus fiber shaft inhibits infectivity in coxsackievirus and adenovirus receptor-positive cell lines.

Authors:  Toshiro Seki; Igor Dmitriev; Elena Kashentseva; Koichi Takayama; Marianne Rots; Kaori Suzuki; David T Curiel
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.

Authors:  Hongju Wu; Igor Dmitriev; Elena Kashentseva; Toshiro Seki; Minghui Wang; David T Curiel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors.

Authors:  K B Elkon; C C Liu; J G Gall; J Trevejo; M W Marino; K A Abrahamsen; X Song; J L Zhou; L J Old; R G Crystal; E Falck-Pedersen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

Review 10.  Enhancing the therapeutic efficacy of adenovirus in combination with biomaterials.

Authors:  Jaesung Kim; Pyung-Hwan Kim; Sung Wan Kim; Chae-Ok Yun
Journal:  Biomaterials       Date:  2011-12-03       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.